BCI
GH icon

Brinker Capital Investments’s Guardant Health GH Stock Holding History

Brinker Capital Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Sell
5,788
-410
-7% -$44.6K 0.01% 1230
2026
Q1 		$573K Buy
6,198
+467
+8% +$46.9K ﹤0.01% 1397
2025
Q4 		$585K Buy
+5,731
New +$513K ﹤0.01% 1528
2024
Q1 		– Sell
-18,200
Closed -$490K – 1709
2023
Q4 		$490K Sell
18,200
-9,869
-35% -$259K 0.01% 1220
2023
Q3 		$832K Sell
28,069
-323
-1% -$11.4K 0.01% 1006
2023
Q2 		$1.02M Buy
28,392
+11,177
+65% +$321K 0.01% 953
2023
Q1 		$404K Buy
17,215
+21
+0.1% +$600 0.01% 1218
2022
Q4 		$468K Sell
17,194
-493
-3% -$22.6K 0.01% 1008
2022
Q3 		$952K Buy
17,687
+8,694
+97% +$446K 0.02% 729
2022
Q2 		$363K Buy
8,993
+1,479
+20% +$73.3K 0.01% 1094
2022
Q1 		$498K Sell
7,514
-2,166
-22% -$148K 0.01% 1046
2021
Q4 		$968K Sell
9,680
-550
-5% -$56.9K 0.01% 829
2021
Q3 		$1.27M Hold
10,230
– – 0.02% 688
2021
Q2 		$1.27M Buy
10,230
+1,407
+16% +$189K 0.02% 740
2021
Q1 		$1.35M Sell
8,823
-10,779
-55% -$1.63M 0.02% 616
2020
Q4 		$2.53M Buy
19,602
+9,772
+99% +$1.12M 0.04% 496
2020
Q3 		$1.1M Buy
+9,830
New +$899K 0.02% 657

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Brinker Capital Investments's GH Position: Q2 2026 in Review

Brinker Capital Investments reduced its Guardant Health (GH) stake by 6.6% in Q2 2026, selling an estimated $44.6K and leaving 5,788 shares worth $868K. The position accounts for 0.01% of the portfolio, ranked #1230.

Brinker Capital Investments first reported a position in GH in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.53M in Q4 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Brinker Capital Investments held 5,788 shares of Guardant Health worth $868K as of Q2 2026.
  • Brinker Capital Investments sold 410 Guardant Health shares in Q2 2026, an estimated $44.6K.
  • Guardant Health made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1230 holding.
  • Brinker Capital Investments first reported a position in Guardant Health in Q3 2020 and has held it in 17 quarters since.
  • Brinker Capital Investments's Guardant Health position peaked at $2.53M in Q4 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.